Jake Bauer

Officer, MyoKardia, Inc.

Companies

BridgeBio Oncology Therapeutics, Inc.Board member Aug 18, 2025 to now¹
Immunovant, Inc.Board member Apr 28, 2025 to now²
Enliven Therapeutics, Inc.Board member Feb 27, 2023 to now³
ARYA Sciences Acquisition Corp VBoard member Jul 12, 2021 to Jul 12, 2021⁴
Cerevel Therapeutics Holdings, Inc.Board member Jun 4, 2020 to Jun 4, 2020⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Enliven Therapeutics, Inc. ELVN87,372 shares⁶$3.3M at $38.33Feb 23, 2023
Immunovant, Inc. IMVT38,896 shares⁷$1.1M at $27.45Apr 7, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 7, 2026Granted 13,880 shares of Immunovant, Inc.⁷
May 1, 2025Granted 25,016 shares of Immunovant, Inc.⁸
Feb 23, 2023Granted 87,372 shares of Enliven Therapeutics, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBridgeBio Oncology Therapeutics, Inc., Board member
2
SEC EDGARImmunovant, Inc., Board member
3
SEC EDGAREnliven Therapeutics, Inc., Board member
4
SEC EDGARARYA Sciences Acquisition Corp V, Board member
5
SEC EDGARCerevel Therapeutics Holdings, Inc., Board member
6
SEC EDGAREnliven Therapeutics, Inc. shares after the filing of Feb 23, 2023
7
SEC EDGARImmunovant, Inc. shares after the filing of Apr 7, 2026
8
SEC EDGARForm 4 filed May 5, 2025